Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.

Ari Rosenberg,Nishant Agrawal,Alexander T. Pearson,Tanguy Y. Seiwert,Zhen Gooi,Elizabeth A. Blair,John F. Cursio,Adam Howard,Jeffrey Chin,Corey C. Foster,Sara Kochanny,Mark W. Lingen,Daniel J. Haraf,Everett E. Vokes

Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.

2020

Ari Rosenberg
Nishant Agrawal
Alexander T. Pearson
Tanguy Y. Seiwert
Zhen Gooi
Elizabeth A. Blair
John F. Cursio
Adam Howard
Jeffrey Chin
Corey C. Foster
Sara Kochanny
Mark W. Lingen
Daniel J. Haraf
Everett E. Vokes

6575Background: Human papilloma virus (HPV) associated oropharyngeal cancer is associated with a favorable prognosis, but standard multimodality treatment is associated with substantial treatment r...

Keywords:

Cancer
Physical therapy
Oncology
De-escalation
Internal medicine
Medicine
long term follow up

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations